Old Web
English
Sign In
Acemap
>
authorDetail
>
Francesco Contegno
Francesco Contegno
European Institute of Oncology
Immunology
Medicine
Valproic Acid
Melanoma
Promyelocytic leukemia protein
4
Papers
177
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A phase I–II study of the histone deacetylase inhibitor valproic acid plus chemoimmunotherapy in patients with advanced melanoma
2009
British Journal of Cancer
A. Rocca
Saverio Minucci
Giulio Tosti
D. Croci
Francesco Contegno
Marco Ballarini
Franco Nolè
Elisabetta Munzone
A. Salmaggi
A. Goldhirsch
P.G. Pelicci
Alessandro Testori
Show All
Source
Cite
Save
Citations (67)
Phase II study with histone deacetylase (HDAC) inhibitor Valproic acid (VPA) in patients with advanced melanoma
2004
Melanoma Research
Andrea Rocca
Giulio Tosti
F. Nolè
Elisabetta Munzone
Giulia Zampino
Nicola Fazio
Laura Orlando
A. Bertuzzi
G. Sanna
Chiara Catania
Saverio Minucci
Francesco Contegno
M. Ballarini
Alessandro Testori
Show All
Source
Cite
Save
Citations (0)
Targeting protein inactivation through an oligomerization chain reaction
2002
Proceedings of the National Academy of Sciences of the United States of America
Francesco Contegno
Mario Cioce
Pier Giuseppe Pelicci
Saverio Minucci
Show All
Source
Cite
Save
Citations (17)
PML-RAR induces promyelocytic leukemias with high efficiency following retroviral gene transfer into purified murine hematopoietic progenitors
2002
Blood
Saverio Minucci
Silvia Monestiroli
Sabrina Giavara
Simona Ronzoni
Francesco Marchesi
Alessandra Insinga
Daniela Diverio
Patrizia Gasparini
Manuela Capillo
Emanuela Colombo
Cristian Matteucci
Francesco Contegno
Francesco Lo-Coco
Eugenio Scanziani
Alberto Gobbi
Pier Giuseppe Pelicci
Show All
Source
Cite
Save
Citations (93)
1